The present invention relates to novel pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt. The present invention provides oral pharmaceutical composition comprising less than of about 45% of mycophenolic acid or salts by total weight of composition and one or more pharmaceutically acceptable excipients. The invention also includes process of preparing such composition.